secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001613103-23-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q3 FY2023 revenue $7.73B (+4.1% organic), non-GAAP EPS $1.30, raises FY guidance
--------------------------------------------------------------------------------

- Revenue $7.727B flat as reported, +4.1% organic; GAAP EPS $0.92 (-16%), non-GAAP EPS $1.30 (-4%), both ahead of expectations.
- Cardiovascular +7% organic, Neuroscience +7% organic; Medical Surgical -2% organic (ex-ventilator/China +3%).
- FY2023 non-GAAP EPS guidance raised to $5.28-$5.30 from $5.25-$5.30; Q4 organic revenue growth expected 4.5-5.0%.
- Planned separations: Respiratory/Patient Monitoring (H2 FY2024) and Renal Care Solutions with DaVita (Q4 FY2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000003/0001613103-23-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000003/mdt-20230221.htm
  HTML page:      https://secwatch.observer/filing/0001613103-23-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer